Skin Disinfectant Solution Manufacturer – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon
Short Description:
Skin Disinfectant Solution Manufacturer – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon Detail:
Major ingredient and concentration
Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) is a disinfectant with Ethacridine Lactate and Dodecyl Dimethyl Benzyl Ammonium Chloride as the main active ingredients. The Ethacridine Lactate content is 0.22g/L-0.022g/L(W/V), and the Dodecyl Dimethyl Benzyl Ammonium Chloride content is 0.42g/L-0.042g/L(W/V).
Germicidal spectrum
Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) can kill the microorganisms such as enteric pathogenic bacteria, pyogenic coccus, pathogenic yeast and hospital infection common germs.
Features and Benefits
1. For rinsing, cleaning and sterilizing the entire skin surface.
List of Uses
Animal care facilities | Military bases |
Community health centers | Operating rooms |
Donning rooms | Orthodonist offices |
Emergency medical settings | Outpatient surgical centers |
Hospitals | Schools |
Laboratories | Surgical centers |
Product detail pictures:
Related Product Guide:
No matter new customer or old customer, We believe in long term and trusted relationship for Skin Disinfectant Solution Manufacturer – Ethacridine Lactate Skin Cleansing Antibacterial Solution (Rivanol) – Lircon, The product will supply to all over the world, such as: Netherlands, Mauritius, Namibia, Our continual availability of high grade products in combination with our excellent pre-sale and after-sales service ensures strong competitiveness in an increasingly globalized market. welcome new and old customers from all walks of life to contact us for future business relationships and mutual success!
By Daniel Coppin from Estonia - 2017.12.19 11:10
The product classification is very detailed that can be very accurate to meet our demand, a professional wholesaler.
By Debby from Argentina - 2018.12.25 12:43